Products

Constellation (CON-001)
Q Bio
Clinical Decision Support & Reference
Constellation (CON-001) is an FDA-cleared AI-powered software by Q Bio for automated whole-body MRI analysis, segmenting anatomical regions and providing quantitative measurements for clinical decision support in preventive healthcare.

See all 1 product →

About Q Bio

Q Bio is a healthcare AI company operating at the intersection of artificial intelligence, physics, and biology, dedicated to transforming preventive and personalized healthcare. The company’s flagship offering is a clinical digital twin platform designed to automate the physical exam process, from comprehensive data collection to intelligent triage and routing for medical professionals.

Utilizing proprietary whole-body scanning technology, such as its Mark I MRI scanner, Q Bio creates a detailed “digital twin” of a patient’s physical body. This platform quantifies and digitizes a vast array of clinically relevant genetic, chemical, and anatomical biomarkers. By integrating this rich dataset with simulated human physiology and advanced machine learning, Q Bio aims to predict potential health risks and highlight significant physiological changes, providing physicians with actionable insights to support earlier intervention and more confident clinical decision-making. The company’s mission is to make comprehensive, proactive health assessments a standard of care, enabling a deeper and continuous understanding of an individual’s health trajectory.

Focus Areas

Preventive health personalized healthcare digital twin technology whole-body MRI scanning AI-assisted analytics multi-omics data integration early disease detection health monitoring radiomics

Business Intelligence

Key InvestorsAndreessen Horowitz (a16z), Khosla Ventures, Founders Fund, Kaiser Foundation Hospitals, TELUS Global Ventures, Alumni Ventures, Arben Ventures, BakerBridge Capital, Evolution (Venture Capital), Beast Ventures, Thirty Five Ventures, XCap, Terry Crews, Sea Lane Ventures, SciFi VC, Kevin Durant
PartnershipsKaiser Foundation Hospitals, TELUS Global Ventures
TechnologyQ Bio Gemini digital twin platform, Mark I whole-body scanner, Tensor Field Mapping (TFM) technology, AI-assisted image analysis software (Constellation), cloud-native platform for data integration and analysis
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

Preventive Health
Q Bio is transforming reactive healthcare into proactive, preventive care by identifying early signs of disease before symptoms manifest, enabling earlier interventions and more precise care.
Personalized Healthcare
The company creates a dynamic, personalized map of each patient's biology by integrating a wide array of individual health data.
Digital Twin Technology
Q Bio builds a 'Digital Twin' for each patient, a data-driven, virtual model of their health, combining whole-body MRI, labs, genetics, and wearables for continuous health monitoring and early disease detection.
Whole-Body MRI Scanning
They utilize a proprietary whole-body MRI platform featuring Tensor Field Mapping (TFM), which provides detailed, harmonized, and quantifiable imaging data, overcoming the qualitative limitations of traditional MRIs. TFM is designed for reproducibility across different machines and clinical settings.
AI-Assisted Analytics
Q Bio employs FDA-cleared AI-powered software (Constellation) to analyze whole-body MR images, segment anatomical regions, and calculate measurements, aiding physicians in visualizing and organizing health information efficiently. The platform also generates personalized health forecasts and recommendations.
Multi-Omics Data Integration
The Gemini Exam integrates comprehensive lab testing (metabolic, lipid, hormone, endocrine, rheumatological, hereditary cancer screens), genetics, imaging, and wearable data, using a 'panomics' approach to create a holistic health snapshot.
Early Disease Detection
A primary focus is to identify disease signs at their earliest stages, even before symptoms appear, to enable interventions that yield the best possible outcomes.
Health Monitoring
The Digital Twin platform facilitates continuous health monitoring, offering trend insights from longitudinal data to support informed clinical decisions.
Radiomics
Q Bio's TFM technology is pivotal for AI in MRI and personalized medicine, providing consistent and reliable imaging data for accurate disease diagnosis and treatment. Radiomics involves extracting quantitative, high-throughput data from imaging to associate with meaningful biological and clinical information.
Physician Tip

Q Bio offers physicians a comprehensive, integrated, and data-driven view of patient health through their Digital Twin platform and Gemini Exam. This enables earlier identification of disease risks and patterns, supporting more precise and proactive interventions. The quantifiable and reproducible MRI data, powered by Tensor Field Mapping (TFM), reduces subjective interpretation and allows for accurate longitudinal tracking of changes. AI-assisted analytics streamline the visualization and organization of complex health information, providing clear visuals and labeled regions to aid in care plan development. This approach aims to transform reactive care into continuous risk assessment and prevention, potentially improving outcomes for chronic diseases.

The Gemini Digital Twin platform is designed to ingest and structure diverse health data, including genetics, biochemistry, imaging, quantitative anatomical data, vitals, wearable data, and medical/family/social history. Q Bio's cloud platform leverages AWS services such as Amazon S3 for data lakes, and Amazon Redshift Spectrum, Athena, or OpenSearch Service for analytics and queriability, ensuring flexibility and scalability for data management and analysis.

Products by Q Bio

1 product in the directory

Constellation (CON-001)
Q Bio
Clinical Decision Support & Reference
Constellation (CON-001) is an FDA-cleared AI-powered software by Q Bio for automated whole-body MRI analysis, segmenting anatomical regions and providing quantitative measurements for clinical decision support in preventive healthcare.

What the Web Says

Q Bio offers a comprehensive preventative health service that includes whole-body MRI, blood and genetic screening, and a 30-minute consultation with a healthcare professional. The company emphasizes data privacy and control for its members, operating under HIPAA compliance and IRB protocol. While the service is praised for its detailed insights and advanced technology, its high cost and lack of insurance coverage are notable drawbacks.

Overall: Mixed

Strengths

  • Comprehensive preventative health approach
  • Detailed and informative insights from scans and screenings
  • Advanced technology including FDA-cleared image-analysis software and quantifiable MRI
  • HIPAA compliant with strong emphasis on data privacy and member control
  • Early detection of clinically significant high-risk factors
  • Positive work-life balance and professional growth opportunities for employees

Limitations

  • High annual membership cost ($3455)
  • Not covered by insurance
  • Only available in one location for the full check-up
  • Some Reddit users question the actionable insights from genomics
  • Potential for high stress and long hours in some employee roles
  • Limited information available on Glassdoor and Capterra specifically for Q Bio (not to be confused with other similarly named companies)

Based on reviews from: SelfDecode Resources, Q Bio Average Salary and Pay Ranges, Q Bio Careers and Employment | Indeed.com, Q Bio | The Comprehensive Physical Exam for Longitudinal Health, Old MRI, new tricks: Q Bio puts forward quantifiable, reproducible scanning approach, Why I Joined Q Bio - Medium, Reddit

Last updated: 2026-07-18

Videos

News, demos, and interviews about Q Bio.

Loading videos...

Videos load interactively. If none appear, search YouTube for Q Bio →

View all on YouTube

Frequently Asked Questions

Q Bio's platform integrates whole-body MRI, comprehensive lab and genetic testing (multi-omics), and wearable data to create a 'Digital Twin' of a patient's health. This comprehensive data collection, including their proprietary Tensor Field Mapping MRI technology, allows for continuous monitoring and the identification of subtle changes over time, supporting proactive health decisions and early disease detection.
Q Bio's 'digital twin' is a dynamic, virtual representation of an individual's biological and physiological state, continuously updated with real-time data from various sources. This technology enables personalized healthcare by allowing clinicians to track health changes, perform predictive simulations, and develop hyper-personalized treatment plans based on a patient's unique and evolving health profile.
Q Bio offers the 'Q Exam,' a comprehensive assessment combining whole-body MRI, lab work, genetics, and wearable data, which results in a personalized health dashboard. The platform utilizes FDA-cleared AI-assisted software for image analysis and health monitoring, helping physicians efficiently visualize and organize health information to support proactive care and track changes over time.
Q Bio states its platform is designed to be HIPAA-compliant, ensuring the privacy and security of Protected Health Information (PHI) in accordance with applicable regulations. Their Tensor Field Mapping MRI technology aims to provide quantifiable and reproducible imaging data, which is crucial for reliable radiomics and AI applications, and they advocate for responsible AI use with clear guidelines.
The Q Exam is priced at $3,495 for an annual exam, which includes a 30-minute telemedicine data review. Q Bio aims to partner with clinics, offering a purpose-built platform for seamless integration into existing models to facilitate rich data integration and support a new class of preventive services.
Q Bio has secured significant funding from prominent investors, including Andreessen Horowitz, Founders Fund, and Khosla Ventures, indicating strong financial backing. The company is actively seeking healthcare partners to expand access to its technology and is focused on accelerating manufacturing and regulatory approvals, demonstrating a commitment to growth and stability in the preventive health sector.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.